Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Vital Energy Reports Third-Quarter 2025 Financial and Operating Results
-
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of October 31, 2025
-
VRANKEN-POMMERY MONOPOLE : Availability Preparatoy Documents of Extraordinary General Meeting of 24th November 2025
-
Pimco Closed-End Funds Declare Monthly Common Share Distributions
-
AltaGas to Retain MVP as Long-Term Investment; Announces $400 Million Bought Deal Financing
-
Ryman Hospitality Properties, Inc. Reports Third Quarter 2025 Results
-
Fabrinet Announces First Quarter Fiscal Year 2026 Financial Results
-
XAI Madison Equity Premium Income Fund Declares its Monthly Distribution of $0.060 per Share
-
XAI Octagon Floating Rate & Alternative Income Trust Declares its Monthly Common Shares Distribution of $0.070 per Share
-
RCM Technologies, Inc. Announces Conference Call
-
COMSTOCK RESOURCES, INC. REPORTS THIRD QUARTER 2025 FINANCIAL AND OPERATING RESULTS
-
NANOBIOTIX to Participate in Investor Conferences the Week of November 10th
-
Diversified Energy Achieves Strong Quarterly Results and Raises 2025 Financial Guidance
-
Matador Technologies Inc. Announces Updated Terms of USD$100 Million Convertible Note Facility to Expand Bitcoin Holdings
-
Skycorp Solar Group Limited Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
-
Greenlight Re Announces Financial Results for Third Quarter and Nine Months Ended September 30, 2025
-
Upwork Reports Third Quarter 2025 Financial Results
-
Diversified Energy Announces Third Quarter Dividend
-
CAUT available to comment on post-secondary education and research in the federal budget
-
Bogota Financial Corp. Reports Results for the Three and Nine Months Ended September 30, 2025
-
Compass Diversified Announces Extension of Credit Agreement Forbearance
-
UFP Technologies Announces Strong Q3 2025 Results
-
Beta Bionics Announces Participation at Upcoming Investor Conferences
-
The Ensign Group Reports Third Quarter 2025 Results; Raises Annual Earnings and Revenue Guidance
-
Castle Biosciences Reports Third Quarter 2025 Results
-
Myriad Genetics Reports Third Quarter 2025 Financial Results; Reiterates 2025 Financial Guidance Following Continued Solid Execution
-
Mobile Infrastructure Announces Timing of Third Quarter 2025 Earnings Release and Conference Call
-
ThredUp Announces Third Quarter 2025 Results
-
Hudson Technologies Announces CEO Departure and Succession Plan
-
Eagle Bancorp, Inc. Announces Leadership Transition
-
Armada Hoffler Reports Third Quarter 2025 Results
-
Bitterroot Bio to Present Anti-CD47 Research at American Heart Association Annual Scientific Session 2025
-
iMDx to Release Third Quarter 2025 Results on November 10 and Attend Stephens Annual Investment Conference the Following Week
-
Reed’s Reports Third Quarter 2025 Results
-
Superior Group of Companies Reports Third Quarter 2025 Results
-
Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Abivax Announces Patient-Reported Outcomes Data from the Phase 3 ABTECT Induction Trials of Obefazimod, Demonstrating Significant Improvements in Quality of Life for Patients with Moderate-to-Severely
-
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Ormat Technologies Reports Third Quarter 2025 Financial Results
-
Solid Biosciences Reports Third Quarter 2025 Financial Results and Provides Update on INSPIRE DUCHENNE Clinical Trial Progress and Planned Regulatory Discussions
-
Gaia Reports Third Quarter 2025 Results
-
TELA Bio Appoints William Plovanic to Board of Directors
-
James River Announces Third Quarter 2025 Results
-
Flux Power to Host Fiscal First Quarter 2026 Financial Results Conference Call on November 13, 2025
-
Glucotrack, Inc. Encourages Shareholders to Vote
-
ProMIS Neurosciences to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference
-
ThredUp Announces Third Quarter 2025 Results
-
Myriad Genetics Reports Third Quarter 2025 Financial Results; Reiterates 2025 Financial Guidance Following Continued Solid Execution
-
EverQuote Announces Third Quarter 2025 Financial Results
-
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in November

